Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2021-05-27
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Stimulation Therapy for Residents With Dementia in Nursing Homes
NCT06978972
Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial
NCT05860127
Cognitive Stimulation Therapy - Effects on Cognitive and Functional Domains in Dementia - A Retrospective Data Review
NCT06932991
Cognitive Stimulation Study
NCT02067689
Cognitive Training and Brain Stimulation in Prodromal Alzheimer's Disease
NCT04265378
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Community Site 5
CST Implementation community site
Cognitive Stimulation Therapy
Group-based therapy for people living with mild to moderate stage dementia, delivered by two trained facilitators.
Community Site 1
CST Implementation community site
Cognitive Stimulation Therapy
Group-based therapy for people living with mild to moderate stage dementia, delivered by two trained facilitators.
Community Site 2
CST Implementation community site
Cognitive Stimulation Therapy
Group-based therapy for people living with mild to moderate stage dementia, delivered by two trained facilitators.
Community Site 3
CST Implementation community site
Cognitive Stimulation Therapy
Group-based therapy for people living with mild to moderate stage dementia, delivered by two trained facilitators.
Community Site 4
CST Implementation community site
Cognitive Stimulation Therapy
Group-based therapy for people living with mild to moderate stage dementia, delivered by two trained facilitators.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive Stimulation Therapy
Group-based therapy for people living with mild to moderate stage dementia, delivered by two trained facilitators.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* has a SLUMS score greater than 10.
Exclusion Criteria
* unable to hear well enough to participate in a small group discussion
* severe visual impairment that precludes ability to see most pictures
* unable to remain in a group setting for 45 minutes
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Milta Little, DO
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Durham Center for Senior Life
Durham, North Carolina, United States
Program for All Inclusive Care of the Elderly
Durham, North Carolina, United States
The Forest at Duke
Durham, North Carolina, United States
Program for All Inclusive Care of the Elderly
Greensboro, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00106751
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.